LONDON (ShareCast) - (Sharecast News) - Healthcare technology company Induction Healthcare announced a strategic collaboration with global health technology company Cerner Corporation on Monday.
The AIM-traded firm said its patient portal for hospitals, 'Zesty', and Cerner would develop a joint patient engagement solution to help NHS trusts deliver a more efficient service for patients.

It said the collaboration would closely align existing patient-facing technology in the UK and Ireland, building on the benefits of its patient portal solution 'Healthelife' and Zesty's integration capability with Cerner's electronic health record (EHR), 'Cerner Millennium'.

The board said NHS trusts were expected to help patients manage outpatient appointments, complete remote care questionnaires, and view hospital correspondence on their own mobile phones, helping to reduce delays and costs associated with posting letters, reducing demands on administrative, medical and nursing staff, and improving patient experience and access to care options.

As part of the value added reseller (VAR) agreement, NHS trusts that are already Cerner clients would have access to Zesty's patient portal under their existing contractual arrangements.

The directors said the strategic collaboration had the potential to generate material revenues for Induction in the year ending 31 March 2022, in keeping with its strategic focus.

"It is a landmark moment for Zesty to be selected by Cerner in the UK and Ireland to jointly develop patient engagement solutions for NHS hospitals," said joint chief executive officer James Balmain.

"Together, our organisations can provide staff and patients with world class digital tools to manage their care and operate more efficiently in the current environment of rapidly changing and unfamiliar conditions.

"The prospect of a patient facing platform that represents the best of Zesty and the best of Cerner will be game-changing for both existing and new Cerner customers."

At 1548 BST, shares in Induction Healthcare were up 24.83% at 93p.

Email this article to a friend

or share it with one of these popular networks:

• DIGG
• FACEBOOK
• STUMBLEUPON
• MIXX
• YAHOO BUZZ
• DELICIOUS
• REDDIT
• NEWSVINE